Simplex Trading’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-49,585
| Closed | -$2.91M | – | 10304 |
|
|
2023
Q4 | $2.91M | Sell |
49,585
-6,848
| -12% | -$385K | ﹤0.01% | 2039 |
|
|
2023
Q3 | $2.46M | Buy |
56,433
+12,270
| +28% | +$438K | ﹤0.01% | 1908 |
|
|
2023
Q2 | $1.59M | Buy |
44,163
+12,375
| +39% | +$510K | ﹤0.01% | 2166 |
|
|
2023
Q1 | $1.18M | Sell |
31,788
-2,700
| -8% | -$121K | ﹤0.01% | 2438 |
|
|
2022
Q4 | $1.56M | Buy |
+34,488
| New | +$2.23M | ﹤0.01% | 2058 |
|
|
2022
Q2 | – | Sell |
-963
| Closed | -$61.2K | – | 11447 |
|
|
2022
Q1 | $79K | Buy |
+963
| New | +$98.5K | ﹤0.01% | 6485 |
|
|
2021
Q4 | – | Sell |
-890
| Closed | -$138K | – | 11719 |
|
|
2021
Q3 | $148K | Hold |
890
| – | – | ﹤0.01% | 6052 |
|
|
2021
Q2 | $143K | Sell |
890
-802
| -47% | -$129K | ﹤0.01% | 6212 |
|
|
2021
Q1 | $289K | Buy |
+1,692
| New | +$335K | ﹤0.01% | 4191 |
|
|
2020
Q3 | – | Sell |
-15,322
| Closed | -$2.1M | – | 8731 |
|
|
2020
Q2 | $1.75M | Buy |
15,322
+10,098
| +193% | +$979K | ﹤0.01% | 1619 |
|
|
2020
Q1 | $401K | Sell |
5,224
-5,642
| -52% | -$506K | ﹤0.01% | 2828 |
|
|
2019
Q4 | $1.4M | Buy |
10,866
+6,651
| +158% | +$642K | ﹤0.01% | 1784 |
|
|
2019
Q3 | $328K | Sell |
4,215
-19,860
| -82% | -$1.86M | ﹤0.01% | 3078 |
|
|
2019
Q2 | $2.48M | Buy |
24,075
+10,640
| +79% | +$828K | 0.01% | 1147 |
|
|
2019
Q1 | $984K | Buy |
13,435
+8,121
| +153% | +$552K | ﹤0.01% | 2009 |
|
|
2018
Q4 | $225K | Buy |
+5,314
| New | +$212K | ﹤0.01% | 3036 |
|
|
2018
Q2 | – | Sell |
-1,602
| Closed | -$60.5K | – | 8028 |
|
|
2018
Q1 | $49K | Buy |
+1,602
| New | +$44.5K | ﹤0.01% | 2469 |
|
|
2017
Q4 | – | Sell |
-77,903
| Closed | -$1.21M | – | 6885 |
|
|
2017
Q3 | $911K | Buy |
77,903
+77,580
| +24,019% | +$449K | 0.04% | 411 |
|
|
2017
Q2 | $1K | Buy |
+323
| New | +$1.24K | ﹤0.01% | 5804 |
|
|
2016
Q4 | – | Sell |
-580
| Closed | -$3.15K | – | 6715 |
|
|
2016
Q3 | $3K | Buy |
580
+509
| +717% | +$2.71K | ﹤0.01% | 4765 |
|
|
2016
Q2 | $0 | Buy |
+71
| New | +$1.13K | ﹤0.01% | 6613 |
|
Other funds holding MRTX
Simplex Trading's MRTX Position: Q1 2024 in Review
Simplex Trading sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 49,585 shares — an estimated $2.91M sold.
Simplex Trading first reported a position in MRTX in Q2 2016 and held it in 21 quarters. The position peaked at $2.91M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Simplex Trading reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Simplex Trading sold 49,585 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.91M.
- Simplex Trading first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2016 and held it in 21 quarters.
- Simplex Trading's Mirati Therapeutics, Inc. Common Stock position peaked at $2.91M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.